Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: Effect of nicotine treatment

Neuroscience

Volumn 152, Issue 1, 2008, Pages 223-233

  Hedberg, M M ^a   Svedberg, M M ^a   Mustafiz, T ^a   Yu, W F ^a   Mousavi, M ^a   Guan, Z Z ^a   Unger, C ^a   Nordberg, A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

A ; d(+) nicotine; hAChE Tg APPswe mice; l( ) nicotine; nAChRs

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; BUNGAROTOXIN; GLIAL FIBRILLARY ACIDIC PROTEIN; NICOTINE; SYNAPTOPHYSIN;

ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFECT; ENANTIOMER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETYLCHOLINESTERASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MUTATION; NICOTINE; NICOTINIC AGONISTS; RECEPTORS, NICOTINIC; SYNAPTOPHYSIN;

EID: 39649122849     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.11.022     Document Type: Article

References (44)

1. Alkondon M., Reinhardt S., Lobron C., Hermsen B., Maelicke A., and Albuquerque E.X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. II. The rundown and inward rectification of agonist-elicited whole-cell currents and identification of receptor subunits by in situ hybridization. J Pharmacol Exp Ther 271 (1994) 494-506
2. Bartolini M., Bertucci C., Cavrini V., and Andrisano V. beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies. Biochem Pharmacol 65 (2003) 407-416
3. Bednar I., Paterson D., Marutle A., Pham T.M., Svedberg M., Hellström-Lindahl E., Mousavi M., Court J., Morris C., Perry E., Mohammed A., Zhang X., and Nordberg A. Selective nicotinic receptor consequences in APP(SWE) transgenic mice. Mol Cell Neurosci 20 (2002) 354-365
4. Beeri R., Andres C., Lev-Lehman E., Timberg R., Huberman T., Shani M., and Soreq H. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr Biol 5 (1995) 1063-1071
5. Blennow K., de Leon M., and Zetterberg H. Alzheimer's disease. Lancet 368 (2006) 387-403
6. Cohen O., Erb C., Ginzberg D., Pollak Y., Seidman S., Shoham S., Yirmiya R., and Soreq H. Neuronal overexpression of "readthrough" acetylcholinesterase is associated with antisense-suppressible behavioral impairments. Mol Psychiatry 7 (2002) 874-885
7. Cummings J.L. Alzheimer's disease. N Engl J Med 351 (2004) 56-67
8. Das P., Murphy M.P., Younkin L.H., Younkin S.G., and Golde T.E. Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition. Neurobiol Aging 22 (2001) 721-727
9. Dineley K.T., Westerman M., Bui D., Bell K., Ashe K.H., and Sweatt J.D. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease. J Neurosci 21 (2001) 4125-4133
10. Erb C., Troost J., Kopf S., Schmitt U., Löffelholz K., Soreq H., and Klein J. Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase. J Neurochem 77 (2001) 638-646
11. Guan Z.Z., Zhang X., Ravid R., and Nordberg A. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J Neurochem 74 (2000) 237-243
12. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
13. Hellström-Lindahl E., Court J., Keverne J., Svedberg M., Lee M., Marutle A., Thomas A., Perry E., Bednar I., and Nordberg A. Nicotine reduces A beta in the brain and cerebral vessels of APPsw mice. Eur J Neurosci 19 (2004) 2703-2710
14. Hoozemans J.J., Chafekar S.M., Baas F., Eikelenboom P., and Scheper W. Always around, never the same: pathways of amyloid beta induced neurodegeneration throughout the pathogenic cascade of Alzheimer's disease. Curr Med Chem 13 (2006) 2599-2605
15. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274 (1996) 99-102
16. Inestrosa N.C., and Alarcon R. Molecular interactions of acetylcholinesterase with senile plaques. J Physiol Paris 92 (1998) 341-344
17. Inestrosa N.C., Alvarez A., Perez C.A., Moreno R.D., Vicente M., Linker C., Casanueva O.I., Soto C., and Garrido J. Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 16 (1996) 881-891
18. Levites Y., Das P., Price R.W., Rochette M.J., Kostura L.A., McGowan E.M., Murphy M.P., and Golde T.E. Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model. J Clin Invest 116 (2006) 193-201
19. McAllister-Sistilli C.G., Caggiula A.R., Knopf S., Rose C.A., Miller A.L., and Donny E.C. The effects of nicotine on the immune system. Psychoneuroendocrinology 23 (1998) 175-187
20. Morel N., Leroy J., Ayon A., Massoulié J., and Bon S. Acetylcholinesterase H and T dimers are associated through the same contact. J Biol Chem 275 (2001) 37379-37389
21. Moore S.A., Huckerby T.N., Gibson G.L., Fullwood N.J., Turnbull S., Tabner B.J., El-Agnaf O.M., and Allsop D. Both the D-(+) and L-(-) enantiomers of nicotine inhibit Abeta aggregation and cytotoxicity. Biochemistry 43 (2004) 819-826
22. Mousavi M., and Nordberg A. Expression of the alpha7, alpha4 and alpha3 nicotinic receptor subtype in the brain and adrenal medulla of transgenic mice carrying genes coding for human AChE and beta-amyloid. Int J Dev Neurosci 24 (2006) 269-273
23. Nagele R.G., D'Andrea M.R., Anderson W.J., and Wang H.Y. Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 110 (2002) 199-211
24. Newhouse P.A., Potter A., and Singh A. Effects of nicotinic stimulation on cognitive performance. Curr Opin Pharmacol 4 (2004) 36-46
25. Nordberg A. Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. Biol Psychiatry 49 (2001) 200-210
26. Nordberg A., Lundqvist H., Hartvig P., Lilja A., and Långström B. Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains-in vivo assessment using positron emission tomography. Alzheimer Dis Assoc Disord 9 (1995) 21-27
27. Nordberg A., Hellström-Lindahl E., Lee M., Johnson M., Mousavi M., Hall R., Perry E., Bednar I., and Court J. Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw). J Neurochem 81 (2002) 655-658
28. O'Callaghan J.P. Quantification of glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISA. Neurotoxicol Teratol 13 (1991) 275-281
29. Oddo S., Caccamo A., Green K.N., Liang K., Tran L., Chen Y., Leslie F.M., and LaFerla F.M. Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. Proc Natl Acad Sci U S A 102 (2005) 3046-3051
30. Ono K., Hasegawa K., Yamada M., and Naiki H. Nicotine breaks down preformed Alzheimer's beta-amyloid fibrils in vitro. Biol Psychiatry 52 (2002) 880-886
31. Rees T., Hammond P.I., Soreq H., Younkin S., and Brimijoin S. Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. Neurobiol Aging 24 (2003) 777-787
32. Rees T.M., Berson A., Sklan E.H., Younkin L., Younkin S., Brimijoin S., and Soreq H. Memory deficits correlating with acetylcholinesterase splice shift and amyloid burden in doubly transgenic mice. Curr Alzheimer Res 2 (2005) 291-300
33. Reyes A.E., Chacon M.A., Dinamarca M.C., Cerpa W., Morgan C., and Inestrosa N.C. Acetylcholinesterase-Abeta complexes are more toxic than Abeta fibrils in rat hippocampus: effect on rat beta-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss. Am J Pathol 164 (2004) 2163-2174
34. Small D.H., Maksel D., Kerr M.L., Ng J., Hou X., Chu C., Mehrani H., Unabia S., Azari M.F., Loiacono R., Aguilar M.I., and Chebib M. The beta-amyloid protein of Alzheimer's disease binds to membrane lipids but does not bind to the alpha7 nicotinic acetylcholine receptor. J Neurochem 101 (2007) 1527-1538
35. Talesa V.N. Acetylcholinesterase in Alzheimer's disease. Mech Ageing Dev 122 (2001) 1961-1969
36. Terai K., Iwai A., Kawabata S., Sasamata M., Miyata K., and Yamaguchi T. Apolipoprotein E deposition and astrogliosis are associated with maturation of beta-amyloid plaques in betaAPPswe transgenic mouse: Implications for the pathogenesis of Alzheimer's disease. Brain Res 900 (2001) 48-56
37. Unger C., Svedberg M.M., Schutte M., Bednar I., and Nordberg A. Effect of memantine on the alpha 7 neuronal nicotinic receptors, synaptophysin- and low molecular weight MAP-2 levels in the brain of transgenic mice over-expressing human acetylcholinesterase. J Neural Transm 112 (2005) 255-268
38. Unger C., Svedberg M.M., Yu W.F., Hedberg M.M., and Nordberg A. Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice. J Pharmacol Exp Ther 317 (2006) 30-36
39. Wang H.Y., Lee D.H., D'Andrea M.R., Peterson P.A., Shank R.P., and Reitz A.B. beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J Biol Chem 275 (2000) 5626-5632
40. White A.R., Barnham K.J., and Bush A.I. Metal homeostasis in Alzheimer's disease. Expert Rev Neurother 6 (2006) 711-722
41. Yu W.F., Guan Z.Z., Bogdanovic N., and Nordberg A. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques. Exp Neurol 192 (2005) 215-225
42. Zhang J., Liu Q., Chen Q., Liu N.Q., Li F.L., Lu Z.B., Qin C., Zhu H., Huang Y.Y., He W., and Zhao B.L. Nicotine attenuates beta-amyloid-induced neurotoxicity by regulating metal homeostasis. FASEB J 20 (2006) 1212-1214
43. Zhang X., and Nordberg A. The competition of (-)-[3H]nicotine binding by the enantiomers of nicotine, nornicotine and anatoxin-a in membranes and solubilized preparations of different brain regions of rat. Naunyn Schmiedebergs Arch Pharmacol 348 (1993) 28-34
44. Zhang X., Gong Z.H., and Nordberg A. Effects of chronic treatment with (+)- and (-)-nicotine on nicotinic acetylcholine receptors and N-methyl-D-aspartate receptors in rat brain. Brain Res 644 (1994) 32-39